Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.

瑞戈非尼通过调节 miR-34a 相关信号通路抑制结肠肿瘤发生和耐药性癌症干细胞样细胞的产生